Prot# 100310: A 12 Week, Double-Blind, Placebo-Controlled Study to Assess the Tolerability, Efficacy and Safety of Ropinirole Dosed PRN in Subjects with Restless Legs Syndrome (RLS) Who Respond to Open-Label Treatment with Ropinirole (TREAT RLS PRN)